Severe recalcitrant pyoderma gangrenosum treated with infliximab.
Kaur
M R
MR
Lewis
H M
HM
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001132:Arm; D002908:Chronic Disease; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007868:Leg Dermatoses / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab